Skip to Content

Rule

Ophthalmic and Topical Dosage Form New Animal Drugs; Ivermectin Pour-On

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule.

SUMMARY:

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Med-Pharmex, Inc. The ANADA provides for topical use of ivermectin on cattle for treatment and control of various species of external and internal parasites.

DATES:

This rule is effective March 5, 2001.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Lonnie W. Luther, Center for Veterinary Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0209.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

Med-Pharmex, Inc., 2727 Thompson Creek Rd., Pomona, CA 91767-1861, filed ANADA 200-299 for Ivermectin Pour-On for Cattle. The application provides for topical use of 0.5 percent ivermectin solution on cattle for the treatment and control of various species of gastrointestinal nematodes, lungworms, grubs, horn flies, lice, and mites. Med-Pharmex's Ivermectin Pour-On for Cattle is approved as a generic copy of Merial Limited’s IVOMEC® (ivermectin) Pour-On for Cattle, approved under NADA 140-841. ANADA 200-299 is approved as of December 28, 2000, and the regulations in § 524.1193 (21 CFR 524.1193) are amended to reflect the approval. The basis of approval is discussed in the freedom of information summary. Section 524.1193 is further revised to reflect current format and to reflect the expiration of 3 years of marketing exclusivity granted to Merial Ltd,. in 1997 (62 FR 38907, July 21, 1997), for which revisions were made to § 524.1193 (63 FR 44384, August 19, 1998).

In accordance with the freedom of information provisions of 21 CFR part 20 and 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.

The agency has determined under 21 CFR 25.33(a)(1) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

Start List of Subjects

List of Subjects in 21 CFR Part 524

End List of Subjects Start Amendment Part

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine,

End Amendment Part Start Part

PART 524—OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS

End Part

1. The authority citation for 21 CFR part 524 continues to read as follows:

Start Authority

Authority: 21 U.S.C. 360b.

End Authority Start Amendment Part

2. Section 524.1193 is amended in paragraph (a) by adding “(mL)” after “milliliter”; by revising paragraph (b); by redesignating paragraph (d) as paragraph (e) and by adding new paragraph (d); and by revising redesignated paragraph (e) to read as follows:

End Amendment Part
Ivermectin pour-on.
* * * * *

(b) Sponsors. See Nos. 050604, 051259, and 059130 in § 510.600(c) of this chapter for use as in paragraph (e) of this section.

* * * * *

(d) Special considerations. See § 500.25 of this chapter.

(e) Conditions of use. (1) Amount. One mL per 22 pounds of body weight.

(2) Indications for use in cattle. It is used topically for the treatment and control of: Gastrointestinal roundworms (adults and fourth-stage larvae) Ostertagia ostertagi (including inhibited stage), Haemonchus placei, Trichostrongylus axei, T. colubriformis, Cooperia spp., Oesophagostomum radiatum; (adults) O. venulosum, Strongyloides papillosus, Trichuris spp.; lungworms (adults and fourth-stage larvae) Dictyocaulus viviparus; cattle grubs (parasitic stages) Hypoderma bovis, H. lineatum; mites Chorioptes bovis, Sarcoptes scabei var. bovis; lice Linognathus vituli, Haematopinus eurysternus, Damalina bovis, Solenoptes capillatus; horn flies Haematobia irritans. It is also used to control infections of gastrointestinal roundworms O. ostertagi, O. radiatum, H. placei, T. axei, Cooperia punctata, and C. oncophora for 14 days after treatment.

(3) Limitations. Do not treat cattle within 48 days of slaughter. Because a withdrawal time in milk has not been established, do not use in female dairy cattle of breeding age.

Start Signature

Dated: February 12, 2001.

Stephen F. Sundlof,

Director, Center for Veterinary Medicine.

End Signature End Supplemental Information

[FR Doc. 01-5221 Filed 3-2-01; 8:45 am]

BILLING CODE 4160-01-S